Electronic Health Reporter

Nearly 100 percent of chief medical information officers (CMIOs) in U.S. hospitals believe medication management improvement initiatives are having a positive impact and that patient safety issues are less likely to occur today as compared to five years ago, according to a new survey from the Association of Medical Directors of Information Systems (AMDIS). The survey of physician leaders, sponsored by DrFirst, also revealed that CMIOs believe there is more work to be done to address gaps that could potentially impact patient safety.

Among the top patient safety gaps identified by CMIOs is the “inability to prevent financial constraints” from impacting patients’ adherence to prescribed medications. In fact, 71 percent of the survey respondents cited concerns with the lack of price transparency—the ability to inform patients how much a prescribed medication will cost, including their insurance co-pay amount. Medication costs are a key concern for patients as well, as evidenced by a Truven Health Analytics-NPR Health Poll which found that 67 percent of patients who failed to fill their prescriptions in the last 90 days reported high costs as their reason.

Addressing high drug prices is also a priority for the Trump administration, which earlier this year introduced the American Patients First blueprint, a comprehensive plan to bring down prescription drug prices and out-of-pocket costs.

The surveyed CMIOS also identified a major gap related to the opioid epidemic. Sixty-five percent of respondents cited the need for an integrated clinician workflow that makes it easy for clinicians to coordinate the entire medication management process, including electronic prescribing of controlled substances like opioids, access to state Prescription Drug Monitoring Programs (PDMPs) to identify patients’ opioid histories, and electronic access to prescriptions from other providers and locations to avoid potentially harmful drug combinations. Similarly, 41 percent shared concerns about providers’ abilities to prevent opioid abuse since they often cannot easily distinguish “drug shoppers” from genuine patients.

Overall, 82 percent of surveyed CMIOs concur that medication management improvement initiatives have had a positive impact on adverse drug events. However, only half of the CMIOs expressed satisfaction with the medication management process, while 12 percent indicated dissatisfaction. According to the survey, the biggest gaps in the entire medication management process are incomplete patient medication histories (80 percent) and misaligned medication reconciliation and care transition cycles that lead to misinformed decisions by care teams (75 percent).

“While the industry has clearly made significant strides to improve medication management processes, CMIOs remain troubled by a number of gaps that compromise patient safety and quality outcomes,” said G. Cameron Deemer, president of DrFirst. “That’s why DrFirst has remained firmly committed to addressing these pain points with innovative new technologies that make a meaningful difference in patient care and the physician experience.”

Continue Reading